Prevention of the OKT3 first-dose syndrome by reduced initial dose followed by adjusted doses based on CD3 T-lymphocyte counts in pediatric renal graft recipients

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 28; no. 6; p. 3466
Main Authors Piatosa, B, Grenda, R, Prokurat, S
Format Journal Article
LanguageEnglish
Published United States 01.12.1996
Subjects
Adolescent
Antigens, CD - analysis
CD3 Complex - analysis
Child
Creatinine - blood
Dose-Response Relationship, Drug
Fluorescent Antibody Technique, Indirect
Follow-Up Studies
Graft Rejection - immunology
Humans
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - adverse effects
Kidney Transplantation - immunology
Kidney Transplantation - physiology
Lymphocyte Count
Muromonab-CD3 - administration & dosage
Muromonab-CD3 - adverse effects
Syndrome
T-Lymphocytes - immunology
Time Factors
Online AccessGet more information

Cover

More Information
ISSN:0041-1345